AI 聊天
Loading data for RXST — first visit, this takes a few seconds.

RxSight, Inc.

RXST · NasdaqGM · USD

6.02 +0.06 (1.01%)

收盤價: Sep 11, 2026, 8:00 PM

6.02 +0.00%

盤後: 7:30 PM

市值
$250.4M
下次財報日期
Aug 5, 2024

RxSight, Inc.(RXST)股價、分析與資料

內在價值

正在載入內在價值…

分析師預測

股票預測 →

分析師預測無法取得

12個月目標價 · n/a 位分析師

分析師共識: n/a

間隔:1D
正在載入K線和訊號…

財務表現

查看財務 →
營收 (ttm)
$127.6M

正在載入...

最新財報

已通報較預期YoY 變更
營收$33.74Mn/a+0.31%
EPS-$0.11+$0.08-37.50%

下次財報

收盤後。

估計 · 升級 →

查看財報詳情 →

指標

買價
4.45
市值
250M
淨利(ttm)
-46.9M
1.16
-1.15
n/a
-8.64
P/B (ttm)
0.95
P/S (ttm)
1.96
財報日期
Aug 5, 2024
賣價
7.8
成交量
450,632
20 日平均成交量
1,101,098
開盤價
6.00
前收盤價
5.96
當日區間
5.78 - 6.03
52 週範圍
4.48 - 13.22
股利
n/a
除息日
n/a

關於 RxSight, Inc.

查看公司資料 →
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California. Medical Devices · Healthcare

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

類股 Healthcare
IPO 日期 Jul 30, 2021
員工 461
證券交易所 NasdaqGM
股票代號 RXST